Moderna

Stories 61 - 77 | << Prev 

With Vaccines on Deck for Distribution, a 'Real Concern'

After seeing numbers, governors worry there aren't enough initial doses

(Newser) - This week, a federal advisory panel recommended health care workers be among the first to get the COVID-19 vaccine when it's authorized for use. And in a document viewed by CBS News , Operation Warp Speed officials say 6.4 million doses of the Pfizer vaccine would be ready to...

Latest Vaccine Numbers Include a Hopeful Stat

Not a single person who received Moderna's candidate developed severe COVID

(Newser) - Monday brought more good news on the vaccine front, with Moderna announcing that it will seek emergency authorization for its candidate. The takeaway stat getting most of the attention is that final results suggest the two-dose vaccine is an impressive 94.1% effective. A post at Science , however, highlights a...

Moderna Takes Next Big Step on Vaccine

Company asks US, EU regulators for approval after results come back 94.1% effective

(Newser) - Moderna Inc. said it would ask US and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection—ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must succeed for the world...

Footnote in Vaccine News Credits a Familiar Face

Dolly Parton's $1M donation to Vanderbilt helped fund Moderna's vaccine

(Newser) - Everyone was so excited by the New England Journal of Medicine's announcement that Moderna's COVID-19 vaccine was shown to be 94.5% effective that many missed the footnote giving partial credit to a country music superstar. Back in April, Dolly Parton donated $1 million to Vanderbilt University Medical...

Moderna&#39;s Vaccine May Have Key Edge Over Pfizer&#39;s
Moderna's Vaccine May Have
Key Edge Over Pfizer's
The rundown
Nov 16, 2020 12:52 PM CST

Moderna's Vaccine May Have Key Edge Over Pfizer's

It can be stored more easily in standard refrigerators

(Newser) - Monday morning brought more hopeful news about a coronavirus vaccine , this time from Moderna. The company announced that its candidate, still in late-stage trials, appears to be 94.5% effective. That's even better than the 90% rate reported by Pfizer last week. Related coverage:
  • First doses: Moderna is on
...

Biden, Trump Respond to Vaccine News

President wants the record to show it came under his watch

(Newser) - Both President Trump and Joe Biden were happy to hear good news about a second possible coronavirus vaccine Monday morning:
  • Trump: "Another Vaccine just announced," he tweeted . "This time by Moderna, 95% effective. For those great 'historians', please remember that these great discoveries, which will end
...

Moderna Reports Great News on Its Vaccine

Early results suggest it's nearly 95% effective

(Newser) - A week ago, Pfizer reported excellent early results on its COVID vaccine. Now, a second major contender also is reporting data, and the results are even better. Moderna announced Monday that preliminary results suggest its coronavirus vaccine is 94.5% effective, reports Reuters . Pfizer's figure was 90%. The upshot...

Pfizer CEO Sold Big Chunk of Shares on Day of Vaccine News

He sold $5.6M in shares as price soared

(Newser) - Pfizer CEO Albert Bourla sold a big chunk of his shares on the same day the company announced very promising news on a coronavirus vaccine , according to an SEC filing. Bourla sold shares worth $5.6 million as the company's stock price soared on Monday, but the company says...

Moderna Updates Its Coronavirus Vaccine Timeline

Not the kind of update you want to hear

(Newser) - Moderna has updated the world on the timeline for its coronavirus vaccine, and as far as the general population is concerned, we're looking at spring. CBS News reports that on Wednesday, CEO Stephane Bancel said the soonest the company might seek emergency authorization for the vaccine, which would give...

Moderna CEO: It Might Be a Year Before You Get a Vaccine

Initial data review expected in November

(Newser) - Moderna plans to seek emergency approval of its coronavirus vaccine candidate once data shows it to be at least 70% effective—but that's not likely to occur before November and perhaps not until mid-2021. That's according to the company's 135-page plan for analyzing trial data, released Thursday....

Bill Gates: US Pandemic Response is 'Shocking'

He also doesn't expect a vaccine before Election Day

(Newser) - Bill Gates has some bad news for President Trump, who has suggested that a coronavirus vaccine could be available by Election Day. Gates tells CNBC that he doesn't see it happening. "None of the vaccines are likely to seek approval in the US before the end of October,...

These Americans Will Get a Vaccine First
These Americans Will 
Get a Vaccine First
in case you missed it
Sep 6, 2020 10:10 AM CDT

These Americans Will Get a Vaccine First

In hypothetical plan, CDC lays out guidelines on distribution, to start as early as next month

(Newser) - Public health officials across the country have been told to prepare to distribute a coronavirus vaccine as soon as late October—though the CDC says this is just a hypothetical. In documents sent to health authorities in all states and territories, as well as five major cities (New York, Chicago,...

Biggest Vaccine Study Yet Gets Underway
Largest Vaccine Trial
Yet Gets Underway
the rundown
Jul 27, 2020 9:40 AM CDT

Largest Vaccine Trial Yet Gets Underway

About 30K volunteers will receive shots in tests by Moderna for a coronavirus vaccine

(Newser) - The early, small-scale testing is over, and now the largest trial to date for a COVID-19 vaccine is underway, reports the AP . This one involves the vaccine made by Moderna , and the first of 30,000 volunteers in the US will begin getting shots on Monday. Half will get the...

In Quest for COVID Vaccine, 107K 'Medical Heroes' Emerge

Volunteers coming out in droves to help 4 firms planning on starting phase 3 of clinical trials in fall

(Newser) - In early July, the National Institutes of Health launched a clinical trials network through which it hoped to enroll thousands of volunteers to test potential COVID-19 vaccines. Just a week or so later, more than 107,000 people had signed up. That's a number USA Today says will "...

'I Feel Fantastic,' COVID-19 Vaccine Volunteer Says

Woman in Seattle trial reports no major side effects but still wears a mask to be sure

(Newser) - The first person in the US to receive an experimental vaccine for COVID-19 has provided a medical update, and it's encouraging. "It's been 16 weeks since I had the first dose," Jennifer Haller says. "I feel fantastic." The Washington state woman, an operations manager...

Vaccine May Turn MIT Prof Into a Billionaire
Vaccine May Turn
MIT Prof Into a Billionaire
in case you missed it
May 23, 2020 10:30 AM CDT

Vaccine May Turn MIT Prof Into a Billionaire

Bob Langer has a stake in Moderna

(Newser) - Drug-maker Moderna reported good news Monday about a potential COVID-19 vaccine currently being tested. It was also good news—you might even say great news—for an MIT professor who owns a stake in the company. Bloomberg reports that Bob Langer's piece of the pie is now worth nearly...

Vaccine Results Expected to Give Stock Market a Lift

Dow futures jump 650 points, in part on good news from Moderna trials

(Newser) - The stock market is expected to get off to a strong start on Monday after last week's struggles. Dow futures jumped 650 points, nearly 3%, and part of the reason is a promising report from drug-maker Moderna about a coronavirus vaccine, reports CNBC . The company says its vaccine contender...

Stories 61 - 77 | << Prev 
Most Read on Newser